Syneos Health, Inc. (NASDAQ: SYNH)
Some price data may be temporarily unavailable.
Key Data Points
Syneos Health, Inc. Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Syneos Health, Inc. Company Info
News & Analysis
Will COVID-19 Derail New Drugs?
Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.
Is Syneos Health Stock a Buy?
The company's revenue has more than doubled in just a few years.
4 Healthcare Services Companies to Own for the Future
Many investors aren’t aware of the vital roles contract research organizations fulfill for pharmaceutical and biotech companies -- or of the billions they make each year for their services.
3 Under-the-Radar Healthcare Stocks With Great Growth Potential
These winning stocks don't make many headlines but are quietly delivering strong revenue and earnings growth.
Here's Why Syneos Health Plummeted Today
The biopharmaceuticals solutions company is under investigation by the SEC.
Why Contract Research Organizations Can Be Money-Making Machines for Investors
Find out how CROs profit from the biotech boom no matter what happens in the clinic.
Financial Health
General
Q2 2023 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q2 2023 | YoY Change |
---|
Liabilities
Q2 2023 | YoY Change |
---|
Ratios
Q2 2023 | YoY Change |
---|
Cash Flow
Q2 2023 | YoY Change |
---|
Valuation
Q2 2023 |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.